Compass Therapeutics (CMPX) Enterprise Value (QoQ) (2018 - 2026)

Compass Therapeutics (CMPX) Enterprise Value (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Compass Therapeutics 388.64 Mn 193.96 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 7.06%
Dec 31, 2025 4.74%
Sep 30, 2025 -117.83%
Jun 30, 2025 10.38%
Mar 31, 2025 11.51%
Dec 31, 2024 -7.87%
Sep 30, 2024 19.30%
Jun 30, 2024 6.61%
Mar 31, 2024 -2.70%
Dec 31, 2023 6.87%
Sep 30, 2023 2.99%
Jun 30, 2023 3.66%
Mar 31, 2023 6.11%
Dec 31, 2022 -54.69%
Sep 30, 2022 8.65%
Jun 30, 2022 3.20%
Mar 31, 2022 5.63%
Dec 31, 2021 -466.52%
Mar 31, 2021 15.68%
Dec 31, 2020 15.21%